Menu Search
Equities

Sincere Co Ltd

7782:TYO

Sincere Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)506.00
  • Today's Change-3.00 / -0.59%
  • Shares traded8.90k
  • 1 Year change-6.30%
  • Beta1.8242
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Sincere Co Ltd grew revenues 6.73% from 5.59bn to 5.96bn while net income improved 347.18% from 66.08m to 295.47m.
Gross margin32.40%
Net profit margin4.44%
Operating margin6.97%
Return on assets5.36%
Return on equity10.95%
Return on investment8.94%
More ▼

Cash flow in JPYView more

In 2023, Sincere Co Ltd increased its cash reserves by 93.74%, or 1.06bn. Cash Flow from Financing totalled 1.18bn or 19.75% of revenues. In addition the company generated 246.15m in cash from operations while cash used for investing totalled 376.77m.
Cash flow per share31.09
Price/Cash flow per share17.50
Book value per share395.46
Tangible book value per share303.58
More ▼

Balance sheet in JPYView more

Sincere Co Ltd has a Debt to Total Capital ratio of 45.43%, a higher figure than the previous year's 19.56%.
Current ratio2.26
Quick ratio1.67
Total debt/total equity0.8325
Total debt/total capital0.4543
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 250.00% and 344.24%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
Div yield(5 year avg)1.14%
Div growth rate (5 year)47.58%
Payout ratio (TTM)32.32%
EPS growth(5 years)81.93
EPS (TTM) vs
TTM 1 year ago		55.02
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.